1Rosen G, Tan C, Sanmancechai A, et al. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma[J]. Cancer, 1975,35(3 Suppl) : 936-945.
2Jaffe N. Recent advances in the chemotherapy of metastatic osteogenic sarcoma[J]. Clin Orthop, 1991,270(4):4- 7.
3Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenicsarcoma: selection of post operative adjuvant chemotherapy based on the response of primary tumor to preoperative chemotherapy [J]. Cancer,1982,49(6):1221 -1230.
4Bramwell VH. The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma[J]. Semin Oncol,1997,24(5):561- 571.
5Bacci G, Ferrari S, Longhi A, et al. Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy [J ]. Acta Orthop Scand,2003 74(4) :449-454.
6Longhi A, Pasini E, Bertoni F, et al. Twenty-year follow -up of osteosarcoma of the extremity treated with adjuvant chemotherapy[J]. J Chemother, 2004,16 (6) : 582- 588.
7Rytting M, Pearson P, Raymond AK, et al. Osteosarcoma in preadolescent patients [J]. Clin Orthop Relat Res, 2000,(373) ;39-50.
8Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols[J]. J Clin Oncol,2002,20(3) :776-790.
9Bacci G, Mereuri M, Longhi A, et al. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: a comparision between results obtained n mono in-stitutional and multicenttric trials[J]. Chir Organi Mov,2004,89(4) :283-292.
10Longhi A, Pasini E, Bertoni F, et al. Twenty year follow-up of osteosarcoma of the extremity treated with adjuvant chemotherapy[J]. J Chemother, 2004,16(6) : 582- 588.
3Goorin AM, Shuster J J, Baker A, et al. Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from multiinstitutional osteosarcoma study [J]. J Clin Oncol, 1991,9(4): 600-- 605.
4Ferguson WS, Harris MB, Goorin AM, et al. Presurgicai window of carboplatin and surgery and muitidrug chemotherapy for the treatment of newly diagnosedm etastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial [J]. J Pediatr Hematol Oncol,2001,23(6) :340--348.
5Yonemoto T, Tatezaki S, Ishii T, et al. Prognosis of osteosarcoma with pulmonary metastases at initial presentation is not dismal [J]. Clin Orthop, 1998,349(4):194--199.
6Belli L, Scholl S, Livartowski A, et al. Resection of pulmonary metastases in osteosarcoma. A retrospective analysis of 44 patients [J]. Cancer, 1989,63(12):2546--2555.
7Carter SR, Grimer R J, Snetach RS, et al. Results of thoracotomy in osteogenic sarcoma with pulmonary metastases [J]. Thorax, 1991,46 : 727-- 731.
8Putnam JB,Roth JA. Surgical treatment for pulmonary metastases from sarcoma [J]. Hemat Oncol Clin North Am, 1995,9(4) :869--887.
9Tateishi A, Takeyama N, Higaki S, et al. Clinical features and treatment of pulmonary metastasis in osteosarcoma [J]. Gan No Rinsho. 1983,29(6) : 544--549.
10Skinner KA, Eilber FR, Holmes EC, et al. Surgical treatment and chemotherapy for pulmonary metastases from osteosarcoma [J]. Arch Surg, 1992,127 (9) : 1065--1070.
